从2026年4月起,每年向老年人和退伍军人提供最多500美元的医疗保险,用于《生物多样性公约》的大麻。 Medicare to offer up to $500 yearly for hemp CBD to seniors and veterans starting April 2026.

2026年4月,根据2025年的一项行政命令,Medicare公司将在2026年4月启动一项试点方案,每年向《生物多样性公约》的大麻产品受益者提供500美元。 In April 2026, Medicare will launch a pilot program offering up to $500 annually to beneficiaries for hemp-derived CBD products, following a 2025 executive order. 该倡议由CMS行政长官Mehmet Oz牵头,旨在扩大老年人和退伍军人处理慢性疼痛、睡眠问题和焦虑的渠道。 The initiative, led by CMS Administrator Mehmet Oz, aims to expand access for seniors and veterans managing chronic pain, sleep issues, and anxiety. 虽然支持者强调减少类阿片的潜在潜在好处和实际世界数据的好处,但批评者警告这一举动可能会破坏林业发展局的药物核准标准,并列举了因药效不一致、污染和缺乏临床鉴定而带来的风险。 While supporters highlight potential opioid reduction and real-world data benefits, critics warn the move could undermine FDA drug approval standards, citing risks from inconsistent potency, contamination, and lack of clinical validation. 该方案使人们对制药公司是否公平发展由林业发展局批准的大麻素疗法表示关切,并可能与州法律和联邦监管机构发生冲突。 The program raises concerns about fairness to pharmaceutical companies developing FDA-approved cannabinoid therapies and may create conflicts with state laws and federal regulatory authority.